Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB)

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Ordinary Shares / American Depositary Shares
Shares outstanding: 384,317,619
Number of holders: 10
Total 13F shares, excl. options: 2,876,992
Shares change: +2,876,992
Total reported value, excl. options: $82,600,000
Value change: +$82,600,119
Number of buys: 10
Price: $28.74

Significant Holders of Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) as of Q1 2021

10 filings reported holding CMMB - Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares as of Q1 2021.
Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 2,876,992 shares of 384,317,619 outstanding shares and own 0.75% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (2,578,174 shares), Maven Securities LTD (126,562 shares), CVI Holdings, LLC (93,750 shares), BOOTHBAY FUND MANAGEMENT, LLC (61,761 shares), MEITAV DASH INVESTMENTS LTD (8,311 shares), RENAISSANCE TECHNOLOGIES LLC (7,023 shares), UBS Group AG (834 shares), MORGAN STANLEY (334 shares), Ironwood Financial, llc (167 shares), and Tower Research Capital LLC (TRC) (76 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.